CareLit · DOI-Nachweis · Aktuelle Rheumatologie
Evaluation of Tuberculosis Risk under Interleukin-1 Inhibitor Agents in Patients with Autoinflammatory Diseases: Experience from a Region with Moderate Tuberculosis Prevalence
DOI 10.1055/a-2015-2683
Bibliografische Angaben
Nachweis in CareLit
Autor:innenÖzlem Karakaş, İsmail Dogan, Serdar Can Güven, Şule Erel, Sukran Erten
ZeitschriftAktuelle Rheumatologie
Ausgabe01/2024
Jahrgang / SeitenJg. 49 · S. 49-53
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Background We aimed to investigate the rate of TBC reactivation in patients with autoinflammatory conditions who had been followed up under treatment with IL-1 antagonists in our clinic. We further aimed to evaluate whether latent TBC screening and isoniazid prophylaxis before IL-1 inhibitor treatment is beneficial in the prevention of reactivation. Patients and Methods This study was designed as a cross-se…
Zitieren
Zitierempfehlung
Özlem Karakaş, İsmail Dogan, Serdar Can Güven, Şule Erel, Sukran Erten (2024) Evaluation of Tuberculosis Risk under Interleukin-1 Inhibitor Agents in Patients with Autoinflammatory Diseases: Experience from a Region with Moderate Tuberculosis Prevalence. Aktuelle Rheumatologie, 49 (01), 49-53. https://doi.org/10.1055/a-2015-2683
Mit CareLit weiterarbeiten